Background Bronchiectasis is a long term respiratory condition with an increasing rate of
diagnosis. It is associated with persistent symptoms, repeated infective exacerbations, and …

Introduction: Sars Co-V2 infection has transformed the way we manage respiratory patients
generally and globally. Objectives: Prevalence and whether routine monitoring and active …

E. coli (Escherichia coli) is a frequent bacterial pathogen causing urinary tract infections (UTIs),
and is the second most common agent to cause bacteraemia 1. Since 2003, there has …

Asbestos use has been significantly reduced in the UK since the 1980s. Various presentations
of asbestos related respiratory diseases are described from benign pleural plaques to …

Background: Our Trust covers a population of 330,000, with a dedicated nurse-lead COPD
unit supported by a respiratory consultant for advice. Patients with AECOPD are assessed …

Introduction Risk for Pneumocystis jiroveci (formerly P carinii) pneumonia (PCP) in non-HIV
infected patients has been attributed to several causes including prolonged or intensive …

Introduction: Predicting disease progression and mortality in COPD is difficult, however some
prediction tools exist (eg Gold Standard Framework [GSF]). There is evidence that patients …

Introduction: Predicting disease progression and mortality for COPD patients (pts) is a
challenge. Weekly (Gold Standard Framework) GSF meetings on the respiratory wards identify …

Background: Prolonged hospital stay and unplanned readmissions are indicators of higher
morbidity and mortality with resultant impact on healthcare resources. In September 2016, a …

Background: LTOT has been shown to provide a survival benefit in severe COPD. In UK,
since 2006, following a Royal college directive LTOT prescriptions were to be issued only by …